Do patients with clinically isolated syndrome benefit from treatment with interferon beta1b?
- PMID: 17279081
- DOI: 10.1038/ncpneuro0397
Do patients with clinically isolated syndrome benefit from treatment with interferon beta1b?
Comment on
-
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.Neurology. 2006 Oct 10;67(7):1242-9. doi: 10.1212/01.wnl.0000237641.33768.8d. Epub 2006 Aug 16. Neurology. 2006. PMID: 16914693 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources